Ara
Toplam kayıt 3, listelenen: 1-3
Lymphocyte Monocyte Ratio as a Prognostic Factor in Non-Small Cell Lung Cancer
(Elsevier Science Inc, 2017)
[No Abstract Available]
Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
(Elsevier Science Inc, 2019)
[No Abstract Available]
Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
(Elsevier, 2021)
[No Abstract Available]